Mycopreneur

Jeremy Gardner joins us on the Mycopreneur podcast to share insights about the roles of technology and venture capital in shaping the psychedelic ecosystem of the future. After tremendous early success as a crypto investor, Jeremy has diversified his investments into a range of asset classes and ventures - which includes the emergent psychedelic industry. We dive into a range of topics from artificial intelligence to the future of masculinity to psilocybin mushroom macrodoses, as well as considerations for where to invest in the emergent psychedelics space.Please consider rating, reviewing, and sharing the podcast with a friend. Hosted on Acast. See acast.com/privacy for more information.

Emily Eizen is a multimedia artist and cannabis entrepreneur in Los Angeles.Her work has been featured in High Times, Playboy, and Forbes among other platforms -She joins us on the Mycopreneur podcast to share insights about her creative process, define what equity in the cannabis and psychedelic space means to her, and tell us about how she broke into the cannabis industry.Please consider rating & reviewing the podcast wherever you're listening. Hosted on Acast. See acast.com/privacy for more information.

Joe Moore and Kyle Buller are the Founders of Psychedelics Today, the planetary hub for individuals, practitioners, and professionals exploring psychedelics. They join me to talk about the state of the psychedelics space, which they continue to shape after six years being at the forefront of it. We talk about their Vital training program for psychedelics for professional training in psychedelic therapy and integration, their upcoming Convergence conference from March 30-April 2, 2023 in Los Angeles, and why all of us should focus on ending the drug war and eradicating the DEA above and beyond our own personal pursuits in the space. Please consider rating, reviewing, and sharing the podcast. Hosted on Acast. See acast.com/privacy for more information.

Dustin Robinson is the Managing Principal of Iter Investments and their venture studio Nucleus.He has a background in law and has advised and invested in numerous companies across the cannabis and psychedelics space. On today's podcast, we learn what Dustin and the Iter team look for in a company before investing, why they've decided to launch a crowdfunding campaign for their data-driven Nucleus platform, and why he's still bullish on investing in the psychedelic space despite the poor performance of the market sector over the last year.Please consider rating, reviewing, and sharing the podcast wherever you're listening Hosted on Acast. See acast.com/privacy for more information.

The Award-winning mycologist filmmaker Hamilton Pevec returns to the Mycopreneur podcast to share intel about his recently released film Azurescens: Through A Blue Lens. This film was recently crowned Best Edutainment piece at the Fungi Film Festival, and follows the pilgrimage of mushroom foragers in search of the fabled Psilocybe azurescens mushroom in the Pacific Northwest of the United States while examining the role that these fungi play in the ecology of their ecosystem. Please consider rating, reviewing, and sharing the podcast wherever you're listening. Hosted on Acast. See acast.com/privacy for more information.

Justin Hanka is the Co-Founder and Chief Executive Director of MindBio Therapeutics, world leaders in microdosing of psychedelics,Justin joins the Mycopreneur Podcast from his home in Melbourne, Australia to discuss the rigorous scientific inquiry and data collection that MindBio therapeutics is conducting in Phase 2 clinical trials assessing the medical efficacy of microdosing LSD to treat Major Depressive Disorder. We discuss the process of clinical trials, the data collected from MindBio Therapeutics Phase 1 clinical trials, what regulators need in order to approve psychedelics as a treatment model for Major Depressive Disorder, and the toppling data that is eradicating lingering stigma against psychedelic medicines in the medical establishment and society at large.Please consider rating, reviewing, and sharing the podcast wherever you're listening.  Hosted on Acast. See acast.com/privacy for more information.

Ash Southard is the Co-Founder and CEO of Mushroom Design, a functional mushroom supplement and education company. She drops in on the Mycopreneur podcast to share observations of trends and important topics surfacing in the psychedelic space, as well as to caution against the proliferation of dogma that she has observed in the growing psychedelic retreat space, and more.Please consider rating, reviewing, and sharing the podcast. Hosted on Acast. See acast.com/privacy for more information.

Elan Hagens is a well known mycopreneur in Portland who has been teaching outdoor education and mushroom foraging for over a decade. Today she swings by the podcast to talk about her experience helping to shape Measure 109 in Oregon, her role in the mushroom community, and why getting a dog helped her make it in the world of science and outdoor education. Please consider rating, reviewing, and sharing the podcast Hosted on Acast. See acast.com/privacy for more information.

Just in Townsend is the CEO of MycoMeditations, a world class psilocybin mushroom retreat center in Treasure Beach, Jamaica.We learn about the dynamics of the legal magic mushroom industry in Jamaica, the practicalities inherent to running a premium operation in the mushroom retreat space, the flow of a week at a mushroom retreat with MycoMeditations, and the net positive benefits of having such an operation present on the island of Jamaica.Please consider rating, reviewing, and sharing the podcast. Hosted on Acast. See acast.com/privacy for more information.

Jon Dennis is an Oregon-based attorney specializing in psychedelic law - he is arguably the nation's foremost expert on the newly minted adult use legal psilocybin industry that's just rolled out in Oregon, and today on the pod he demystifies what the final rules and regulations around Oregon's Measure 109 entail.Please consider rating, reviewing, and sharing the podcast Hosted on Acast. See acast.com/privacy for more information.